摘要
通过实地调研与网络调研相结合,运用Logistic回归分析方法,分析影响医药企业技术创新意愿的内外部环境因素,为制定激发医药企业技术创新内在动力的相关政策提供实证依据。结果表明,企业自身技术创新的能力和研发部门人员投入是影响企业技术创新意愿的主要内部因素;专利保护制度和市场进入壁垒是影响企业技术创新意愿的最主要外部因素。因此,企业应合理配置资源投入,提高自身技术创新能力。政府应该完善专利保护政策,保护企业研发成果;营造良好的市场环境,完善新药市场准入制度。
Based on logistic regression analysis,this paper analyzed the internal and external environment factors that affecting the technological innovation intention of pharmaceutical industry,aiming to provide the basis for the government to draw up relevant policies to stimulate the intrinsic motivation of pharmaceutical industry for technological innovation. The analysis showed that the internal factors which could strengthen the willing of enterprises for technological innovation were their own technological innovation ability and RD personnel investment. The significant external factors were patent protection and market entry barriers. It was suggested that the pharmaceutical enterprises allocate resources rationally and improve their own technological innovation ability. The government should complete patent protection policy and protect RD results of pharmaceutical enterprises. Also the government should create a favorable market environment and improve market access system of new drugs.
出处
《中国新药杂志》
CAS
CSCD
北大核心
2017年第1期22-28,共7页
Chinese Journal of New Drugs
基金
国家社会科学基金重大项目(15ZDB167)子课题:我国创新药物发展水平与发展政策环境需求分析
工信部课题"实现我国医药产业由大变强的路径研究"(X153011)
关键词
医药企业
技术创新意愿
影响因素
LOGISTIC回归分析
pharmaceutical industry
technical innovation intention
affecting factors
Logistic regression analysis